Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2021	Apr. 11, 2022	Jun. 30, 2021
Details
Registrant CIK	0001763329
Fiscal Year End	--12-31
Registrant Name	MYCOTOPIA THERAPIES, INC.
SEC Form	10-K/A
Period End date	Dec. 31, 2021
Tax Identification Number (TIN)	87-0645794
Number of common stock shares outstanding		14,322,374
Public Float			$ 6,232,015
Filer Category	Non-accelerated Filer
Current with reporting	Yes
Interactive Data Current	Yes
Voluntary filer	No
Well-known Seasoned Issuer	No
Shell Company	false
Small Business	true
Emerging Growth Company	false
Document Financial Statement Error Correction	false
Amendment Description	Mycotopia Therapies, Inc. (the Company) filed its Annual Report on Form 10-K for the year ended December 31, 2021, with the Securities and Exchange Commission (SEC) on April 14, 2022 (the Original Form 10-K). This Amendment No. 1 on Form 10-K/A (Amendment No. 1 or Form 10-K/A) is being filed to reflect the restatement of accounts payable, common stock, additional paid-in capital, general and administrative expense, net loss, and net loss per share (the Restatement) in the consolidated balance sheet and statement of operations for the year ended December 31, 2021. The Restatement is due to the Company performing an evaluation of its accounting in connection with the employment agreement entered into between the Company and Ben Kaplan, the Companys CEO. Management determined that the Original Form 10-K does not give effect to $288,000 cash compensation and the issuance of a warrant (the Warrant) to purchase shares equal to 5 percent of the fully diluted common stock outstanding of the Company. The cash compensation and Warrant was granted to the Chief Executive Officer of the Company pursuant to his consulting agreement entered into on November 17, 2021. On April 25, 2023, management concluded its evaluation and determined that the identified errors require the filing of Amendment No. 1, as further discussed in Notes 1 and 4 to the consolidated financial statements included in this Form 10-K/A.
Document Annual Report	true
Document Transition Report	false
Entity File Number	000-56022
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	18851 NE 29th Ave.
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Aventura
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33180
City Area Code	954
Local Phone Number	233-3511
Amendment Flag	true
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	FY
Auditor Firm ID	6117
Auditor Name	Pinnacle Accountancy Group of Utah
Auditor Location	Farmington, Utah